Molina Healthcare (MOH) – Analysts’ Recent Ratings Updates

A number of research firms have changed their ratings and price targets for Molina Healthcare (NYSE: MOH):

• 5/11/2026 – Molina Healthcare had its price target raised by Truist Financial Corporation from $180.00 to $205.00. They now have a “hold” rating on the stock.
• 5/11/2026 – Molina Healthcare had its price target raised by Cantor Fitzgerald from $144.00 to $209.00. They now have a “neutral” rating on the stock.
• 5/11/2026 – Molina Healthcare had its price target raised by Robert W. Baird from $124.00 to $163.00. They now have a “neutral” rating on the stock.
• 5/2/2026 – Molina Healthcare was upgraded by Wall Street Zen from “sell” to “hold”.
• 4/29/2026 – Molina Healthcare was upgraded by Bank of America Corporation from “underperform” to “buy”. They now have a $250.00 price target on the stock.
• 4/27/2026 – Molina Healthcare had its price target raised by Wells Fargo & Company from $141.00 to $159.00. They now have an “equal weight” rating on the stock.
• 4/27/2026 – Molina Healthcare had its price target raised by Truist Financial Corporation from $145.00 to $180.00. They now have a “hold” rating on the stock.
• 4/24/2026 – Molina Healthcare had its “hold” rating reaffirmed by Deutsche Bank Aktiengesellschaft. They now have a $129.00 price target on the stock.
• 4/24/2026 – Molina Healthcare had its price target raised by UBS Group AG from $151.00 to $180.00. They now have a “neutral” rating on the stock.
• 4/24/2026 – Molina Healthcare had its price target raised by Morgan Stanley from $128.00 to $146.00. They now have an “equal weight” rating on the stock.
• 4/24/2026 – Molina Healthcare had its price target raised by Barclays PLC from $133.00 to $161.00. They now have an “underweight” rating on the stock.
• 4/21/2026 – Molina Healthcare had its “sell (d+)” rating reaffirmed by Weiss Ratings.
• 4/20/2026 – Molina Healthcare was upgraded by Zacks Research from “strong sell” to “hold”.
• 4/19/2026 – Molina Healthcare was upgraded by Wall Street Zen from “strong sell” to “sell”.
• 4/11/2026 – Molina Healthcare was downgraded by Wall Street Zen from “sell” to “strong sell”.

Insiders Place Their Bets

In other news, insider Jeff D. Barlow sold 17,811 shares of the firm’s stock in a transaction dated Monday, May 11th. The stock was sold at an average price of $186.12, for a total transaction of $3,314,983.32. Following the sale, the insider directly owned 67,175 shares in the company, valued at $12,502,611. This trade represents a 20.96% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CAO Maurice Hebert sold 600 shares of Molina Healthcare stock in a transaction dated Thursday, May 14th. The shares were sold at an average price of $191.55, for a total value of $114,930.00. Following the completion of the transaction, the chief accounting officer owned 12,815 shares of the company’s stock, valued at approximately $2,454,713.25. This represents a 4.47% decrease in their position. The disclosure for this sale is available in the SEC filing. 1.44% of the stock is currently owned by insiders.

Molina Healthcare, Inc is a managed care company specializing in government-sponsored health insurance programs. The company offers Medicaid managed care plans, Medicare Advantage and prescription drug plans, and individual Marketplace plans under the Affordable Care Act. Through an integrated care model, Molina emphasizes preventive and primary care services, care coordination, and disease management to improve health outcomes for its members.

The company traces its roots to the early 1980s, when Dr.